Dr. Vladislav Bekerman, MD

Dr. Bekerman practices at Miramar Eye Specialists Medical Group in Ventura, California.

Dr. Bekerman's NPI, 1285138362, was assigned on March 22, 2018. Dr. Bekerman graduated from Drexel University College Of Medicine in 2017. Dr. Bekerman holds California license A177459.

Dr. Bekerman's primary practice is Miramar Eye Specialists Medical Group, at 3085 Loma Vista Rd, Ventura, CA 93003 in Ventura County. The practice phone is (805) 648-3085.

Dr. Bekerman's primary practice is Miramar Eye Specialists Medical Group in Ventura, California. Dmand AI also links Dr. Bekerman to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bekerman practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Bekerman's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Bekerman is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Bekerman's licenses on file in 3 states: California, New Jersey and Pennsylvania.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Bekerman treats.

CMS data shows 2,374 Medicare services from Dr. Bekerman across 17 procedure codes in 2024, for 696 Medicare patients. Medicare paid $171,414 for them.

CMS counts 696 Medicare patients who saw Dr. Bekerman in 2024. The largest group is 65 to 74, with 308 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.08, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bekerman's median patient age at 73, with 60% women.

In 2024, Dr. Bekerman wrote 2,564 Medicare Part D claims for 715 patients. 53% of them were for generic drugs. CMS names the drug for 2,422 of them, across 30 drugs with 11 or more claims each, at $1,844,302 in total drug cost. In 2023, CMS named 2,349 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Bekerman for performance year 2024, reported as part of a group. Dr. Bekerman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 250 procedures of cataract surgery by Dr. Bekerman, more than 87% of the clinicians it reports for that procedure.

Dmand AI links 9 papers to Dr. Bekerman, published from 2021 to 2024. 2021 was the busiest year, with 2. The most frequent topics are Visual Acuity, Fluorescein Angiography and Fundus Oculi. Dr. Bekerman has published most often in J Neuroophthalmol. Dr. Bekerman's most frequent co-authors are Larry P. Frohman, MD, Arman Mashayekhi, MD and Roger Eric Turbin, MD.

CMS Open Payments shows 99 general payments to Dr. Bekerman from 16 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 97% of the total. Alcon Laboratories Inc paid the most, $775.

Dmand AI lists 1 award for Dr. Bekerman, most recently Magna Cum Laude in 2012.

Dr. Bekerman graduated from Drexel University College Of Medicine in 2017.

Dr. Bekerman is in network with 20 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.